Vaccines

8 June 2013

ImmunoCellular Therapeutics Announces Recommendation of Data Monitoring Committee to Continue ICT-107 Phase II Trial Following Interim Analysis

6 June 2013

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial

6 June 2013

Targovax AS Raises $3.6 Million in Private and Public Support for TG01 Pancreatic Cancer Vaccine Development

6 June 2013

Novavax Produces MERS-CoV Vaccine Candidate

5 June 2013

Generex Announces ASCO Presentations of AE37 Vaccine Data; Potential Leading Immunotherapy Option for Breast Cancer Patients

3 June 2013

Immunovaccine Shows Pronounced and Persistent T Cell Immune Responses in DPX-Survivac Cancer Vaccine Study Presented at American Society of Clinical Oncology (ASCO) Meeting

31 May 2013

Bavarian Nordic’s IMVANEX(r) Smallpox Vaccine Receives Positive Opinion From European Regulatory Authorities

30 May 2013

Sinovac Files New Drug Application for EV71 Vaccine and Receives Filing Acceptance from Beijing Drug Administration

30 May 2013

New European Phase II Trial to Test Immunovaccine’s DPX-Survivac in Brain Cancer Patients

30 May 2013

FDA Lifts Clinical Hold On PharmAthene’s SparVax Anthrax Vaccine Program

29 May 2013

Bavarian Nordic’s CV-301 Cancer Immunotherapy Candidate Shows Promise in Colorectal Cancer

28 May 2013

DCPrime’s Phase I/IIa Trial with Dendritic Cancer Vaccine in Acute Myeloid Leukemia Meets All Clinical Endpoints

22 May 2013

Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors

22 May 2013

iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza

21 May 2013

Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S.

17 May 2013

A*STAR and Cytos Bring Singapore’s First Influenza Vaccine to Clinical Testing

16 May 2013

FANG™ Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer

14 May 2013

Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study

9 May 2013

GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck’s HPV Vaccine, Available to Developing Countries through UNICEF Tender

8 May 2013

Flu Pandemic Fears to Spur Massive Vaccine Market Growth in Philippines

8 May 2013

Medicago successfully produces VLP vaccine candidate for H7N9 virus responsible for recent influenza outbreak in China

8 May 2013

Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet

7 May 2013

Aeras, Oxford University, Okairos: TB, HIV and Malaria Vaccine Research Gets Major Boost

6 May 2013

CEL-SCI Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Score in a Second Animal Model

6 May 2013

ETUBICS PLATFORM GENERATES SOLID IMMUNE RESPONSE IN COLORECTAL CANCER PATIENTS

1 May 2013

Cancer Vaccines Offer Time to Terminal Cases

1 May 2013

Positive Phase 2 Data from Agenus’ Brain Cancer Vaccine Presented at Plenary Session of American Academy of Neurological Surgeons Meeting

29 April 2013

Transgene: Promising Final Data from the Phase 2 HCVac Trial of TG4040 Presented at EASL 2013

29 April 2013

Transgene Presents Promising Pre-Clinical Data on TG1050 to Treat Chronic HBV at EASL 2013

28 April 2013

Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years

News Channels

Newsletter

La Merie Biologics

La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.

Newsletter La Merie Biologics

Newsletter

New Product Alert

La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.

Newsletter new product alert

Featured reports

CD73 Inhibitor Pipeline Review

Blockbuster Biologics 2018: Sales of Recombinant Therapeutic Antibodies & Proteins

2021 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review

EpCAM-Targeted Antibodies Pipeline Review

Blockbuster Biologics 2019: Sales of Recombinant Therapeutic Antibodies & Proteins

TROP-2-Targeted Immunotherapy Pipeline Review

TL1A Inhibitor Pipeline Review

Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective

DLL3-Targeted Immunotherapy Candidates Pipeline Review